Vaccination of blood donors against hepatitis B is feasible, safe and cost–effective

ISSN： 1746-0794

Source： Future Virology, Vol.6, Iss.10, 2011-10, pp. : 1139-1141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Group care intervention `feasible and cost-effective' in diabetes

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 389, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Mass rotavirus vaccination, a cost-effective strategy in India

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 588, 2009-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Alteplase: a Safe and Cost‐Effective Alternative to Urokinase

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 32, Iss. 2, 2002-06 ,pp. : 94-94

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety of immunisation and adverse events following vaccination against hepatitis B

By Duclos Philippe

Expert Opinion on Drug Safety, Vol. 2, Iss. 3, 2003-05 ,pp. : 225-231

Informa Healthcare

Access to resources Recommend Favorite

Use of Routine Healthcare Data in Safe and Cost-Effective Drug Use

By Currie C.J.

Drug Safety, Vol. 22, Iss. 2, 2000-02 ,pp. : 97-102

Adis International

Access to resources Recommend Favorite